Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Douglas Cleary

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Genetics & Development|April 3, 2017
New developments in RAN translation: insights from multiple diseasesJohn Douglas Cleary, Laura Pw Ranum
Current Opinion in Genetics & Development|May 24, 2014
Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disordersJohn Douglas Cleary, Laura P W Ranum
Trends in Pharmacological Sciences|January 14, 2020
Drug Screen Tugs at Common Thread for Repeat DisordersKaalak Reddy, John Douglas Cleary, J Andrew Berglund
Annual Review of Neuroscience|March 27, 2019
Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological DiseaseLien Nguyen, John Douglas Cleary, Laura P W Ranum
The Journal of Biological Chemistry|September 15, 2018
Repeat-associated non-ATG (RAN) translationJohn Douglas Cleary, Amrutha Pattamatta, Laura P W Ranum
Bioanalysis|July 3, 2026
A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1Purnajai Srivijay Saravanan Vanaja, Subodh Mishra, John Douglas Cleary, et al.
JCI Insight|June 15, 2023
Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1Emily E Davey, Cécilia Légaré, Lori Planco, et al.
Iscience|April 28, 2022
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screeningJana R Jenquin, Alana P O'Brien, Kiril Poukalov, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Genetics & Development|April 3, 2017
New developments in RAN translation: insights from multiple diseasesJohn Douglas Cleary, Laura Pw Ranum
Current Opinion in Genetics & Development|May 24, 2014
Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disordersJohn Douglas Cleary, Laura P W Ranum
Trends in Pharmacological Sciences|January 14, 2020
Drug Screen Tugs at Common Thread for Repeat DisordersKaalak Reddy, John Douglas Cleary, J Andrew Berglund
Annual Review of Neuroscience|March 27, 2019
Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological DiseaseLien Nguyen, John Douglas Cleary, Laura P W Ranum
The Journal of Biological Chemistry|September 15, 2018
Repeat-associated non-ATG (RAN) translationJohn Douglas Cleary, Amrutha Pattamatta, Laura P W Ranum
Bioanalysis|July 3, 2026
A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1Purnajai Srivijay Saravanan Vanaja, Subodh Mishra, John Douglas Cleary, et al.
JCI Insight|June 15, 2023
Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1Emily E Davey, Cécilia Légaré, Lori Planco, et al.
Iscience|April 28, 2022
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screeningJana R Jenquin, Alana P O'Brien, Kiril Poukalov, et al.
Pageof 1